Martin Michael Robert
SEC CIK 1837647 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Chief Business Off | 259.2K | $154.8K | $12.78M | 18 | 2021-07-28 | 2023-03-02 |
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Martin Michael Robert made no open-market trades at AUPH in the last 12 months.
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | A - Grant | — | +107.2K | 259.2K | +71% | — | |
| 2022-11-09 | 2022-11-07 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | P - Purchase | $5.16 | +30.0K | 89.5K | +50% | +$154.8K | |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | A - Grant | $0.00 | +8,500 | 64.4K | +15% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale | $12.01 | -4,849 | 59.5K | -8% | -$58.2K |
| DM | 2021-11-12 | 2021-11-09+ | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale+OE | $30.25 | -150.0K | 66.9K | -69% | -$4.54M |
| D | 2021-11-12 | 2021-11-11 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | M - OptEx | $18.38 | +29.0K | 95.9K | +43% | +$533.0K |
| D | 2021-11-03 | 2021-11-01 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale+OE | $31.64 | -45.0K | 176.9K | -20% | -$1.42M |
| D | 2021-11-03 | 2021-11-01 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | M - OptEx | $3.20 | +45.0K | 221.9K | +25% | +$144.0K |
| DM | 2021-09-22 | 2021-09-20+ | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | M - OptEx | $6.89 | +116.0K | 264.4K | +78% | +$798.8K |
| DM | 2021-09-22 | 2021-09-20+ | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale+OE | $23.44 | -116.0K | 176.9K | -40% | -$2.72M |
| DM | 2021-09-16 | 2021-09-14 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale+OE | $21.78 | -44.0K | 206.9K | -18% | -$958.2K |
| D | 2021-09-16 | 2021-09-14 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | M - OptEx | $5.30 | +44.0K | 220.9K | +25% | +$233.2K |
| DM | 2021-09-14 | 2021-09-10+ | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale+OE | $20.89 | -115.0K | 176.9K | -39% | -$2.40M |
| DM | 2021-09-14 | 2021-09-13+ | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | M - OptEx | $4.48 | +115.0K | 201.9K | +132% | +$515.0K |
| 2021-09-08 | 2021-09-07 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale | $18.10 | -7,500 | 176.9K | -4% | -$135.8K | |
| 2021-08-27 | 2021-08-26 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale | $17.81 | -22.5K | 184.4K | -11% | -$400.7K | |
| 2021-08-10 | 2021-08-09 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale | $16.01 | -5,000 | 206.9K | -2% | -$80.1K | |
| 2021-07-29 | 2021-07-28 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Chief Business Off | S - Sale | $13.86 | -5,000 | 211.9K | -2% | -$69.3K |
Purchase Sale Sale after option exercise All abbreviations